0001209191-17-059524.txt : 20171106
0001209191-17-059524.hdr.sgml : 20171106
20171106204521
ACCESSION NUMBER: 0001209191-17-059524
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171102
FILED AS OF DATE: 20171106
DATE AS OF CHANGE: 20171106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDFISCHER CARL
CENTRAL INDEX KEY: 0001110780
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 171180878
MAIL ADDRESS:
STREET 1: 161 WEST 61ST STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-11-02
0
0001042074
CymaBay Therapeutics, Inc.
CBAY
0001110780
GOLDFISCHER CARL
C/O CYMABAY THERAPEUTICS, INC.
7999 GATEWAY BOULEVARD, SUITE 130
NEWARK
CA
94560
1
0
0
0
Common Stock
2017-11-02
4
M
0
9000
1.72
A
9000
D
Common Stock
2017-11-02
4
M
0
9000
2.97
A
18000
D
Common Stock
2017-11-02
4
S
0
18000
8.66
D
0
D
Stock Option (right to buy)
1.72
2017-11-02
4
M
0
9000
0.00
D
2026-06-27
Common Stock
9000
0
D
Stock Option (right to buy)
2.97
2017-11-02
4
M
0
9000
0.00
D
2025-06-23
Common Stock
9000
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.60 to $8.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Fully vested.
/s/ Sujal Shah, Attorney-in-Fact for Carl Goldfischer
2017-11-06